Loading...
OTCM
TLCC
Market cap129kUSD
Mar 25, Last price  
0.00USD
Name

Twinlab Consolidated Holdings Inc

Chart & Performance

D1W1MN
P/E
—
P/S
0.01
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.58%
Rev. gr., 5y
-28.58%
Revenues
14m
-74.10%
84,236,00076,230,00061,426,00081,672,00086,323,00085,501,00073,291,00073,460,00066,349,00072,089,00052,584,00013,617,000
Net income
-14m
L+66.80%
-2,881,000-2,482,000-21,130,000-36,410,000-684,000-29,491,000-20,409,000-44,501,000-14,389,000-14,940,000-8,222,000-13,714,000
CFO
3m
P
-5,987,0003,897,000-14,735,000-1,959,000-25,330,000-6,503,000-6,564,000-8,411,000-5,070,0002,650,000-4,311,0002,897,000
Earnings
Jul 29, 2025

Profile

Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, and sports nutrition products under the Twinlab brand; healthy aging and beauty products under the Reserveage Nutrition and ResVitale brands; diet and energy products under the Metabolife; and a line of herbal teas under the Alvita brand. It also acts as contract manufacturer for private label customers. The company sells its products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, stick packs, sprays, and powders primarily through health and natural food stores, supermarkets, mass market retailers, specialty stores retailers, online retailers, and websites. Twinlab Consolidated Holdings, Inc. was founded in 2013 and is based in Boca Raton, Florida.
URL
https://www.tchhome.com/
IPO date
Jun 25, 2014
Employees
46
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13,617
-74.10%
52,584
-27.06%
Cost of revenue
15,006
54,215
Unusual Expense (Income)
NOPBT
(1,389)
(1,631)
NOPBT Margin
Operating Taxes
43
25
Tax Rate
NOPAT
(1,432)
(1,656)
Net income
(13,714)
66.80%
(8,222)
-44.97%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
96,489
98,540
Long-term debt
5,820
9,235
Deferred revenue
Other long-term liabilities
Net debt
102,290
106,877
Cash flow
Cash from operating activities
2,897
(4,311)
CAPEX
(99)
Cash from investing activities
(99)
Cash from financing activities
(3,744)
1,647
FCF
16,163
7,176
Balance
Cash
19
868
Long term investments
30
Excess cash
Stockholders' equity
(369,744)
(356,000)
Invested Capital
329,405
333,267
ROIC
ROCE
3.44%
7.17%
EV
Common stock shares outstanding
259,093
259,093
Price
0.04
 
Market cap
9,846
 
EV
112,136
EBITDA
(731)
(522)
EV/EBITDA
Interest
8,271
7,902
Interest/NOPBT